Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lower Extremity | 33 | 2024 | 1218 | 2.890 |
Why?
|
Vascular Surgical Procedures | 33 | 2024 | 1506 | 2.640 |
Why?
|
Ischemia | 27 | 2024 | 1904 | 2.430 |
Why?
|
Limb Salvage | 28 | 2024 | 488 | 2.260 |
Why?
|
Peripheral Arterial Disease | 25 | 2024 | 1306 | 2.250 |
Why?
|
Endovascular Procedures | 26 | 2024 | 2218 | 1.860 |
Why?
|
Peripheral Vascular Diseases | 12 | 2012 | 489 | 1.360 |
Why?
|
Blood Vessel Prosthesis Implantation | 21 | 2020 | 1456 | 1.170 |
Why?
|
Veins | 7 | 2018 | 769 | 1.040 |
Why?
|
Femoral Artery | 9 | 2023 | 826 | 1.030 |
Why?
|
Angioplasty | 12 | 2020 | 353 | 1.020 |
Why?
|
Popliteal Artery | 6 | 2023 | 311 | 0.940 |
Why?
|
Angioplasty, Balloon | 11 | 2018 | 591 | 0.930 |
Why?
|
Vascular Grafting | 4 | 2018 | 163 | 0.880 |
Why?
|
Endarterectomy, Carotid | 9 | 2024 | 556 | 0.840 |
Why?
|
Varicose Veins | 3 | 2013 | 158 | 0.830 |
Why?
|
Aortic Aneurysm, Abdominal | 15 | 2022 | 1249 | 0.820 |
Why?
|
Stents | 22 | 2024 | 3191 | 0.710 |
Why?
|
Carotid Stenosis | 6 | 2024 | 857 | 0.580 |
Why?
|
Vascular Patency | 17 | 2024 | 914 | 0.530 |
Why?
|
Graft Occlusion, Vascular | 6 | 2015 | 539 | 0.520 |
Why?
|
Chi-Square Distribution | 27 | 2018 | 3432 | 0.480 |
Why?
|
Intermittent Claudication | 5 | 2016 | 305 | 0.470 |
Why?
|
Time Factors | 52 | 2024 | 40108 | 0.460 |
Why?
|
Blood Vessel Prosthesis | 9 | 2019 | 956 | 0.450 |
Why?
|
Arterial Occlusive Diseases | 4 | 2012 | 742 | 0.450 |
Why?
|
Education, Medical, Graduate | 2 | 2018 | 2419 | 0.430 |
Why?
|
Diabetes Complications | 5 | 2007 | 1318 | 0.430 |
Why?
|
Leg | 6 | 2013 | 1088 | 0.420 |
Why?
|
Wound Healing | 12 | 2024 | 2795 | 0.420 |
Why?
|
Venous Insufficiency | 1 | 2012 | 109 | 0.370 |
Why?
|
Diabetes Mellitus | 10 | 2024 | 5889 | 0.370 |
Why?
|
Treatment Outcome | 64 | 2024 | 65219 | 0.370 |
Why?
|
Aortic Rupture | 5 | 2016 | 322 | 0.360 |
Why?
|
Diabetic Foot | 3 | 2010 | 383 | 0.360 |
Why?
|
Kaplan-Meier Estimate | 14 | 2024 | 6506 | 0.360 |
Why?
|
Risk Factors | 58 | 2024 | 74857 | 0.350 |
Why?
|
Saphenous Vein | 4 | 2020 | 519 | 0.330 |
Why?
|
Kidney Failure, Chronic | 5 | 2016 | 2504 | 0.320 |
Why?
|
Quality Indicators, Health Care | 6 | 2016 | 1804 | 0.320 |
Why?
|
Diabetic Angiopathies | 2 | 2005 | 805 | 0.320 |
Why?
|
Creatinine | 4 | 2013 | 1916 | 0.290 |
Why?
|
Risk Assessment | 29 | 2024 | 24276 | 0.280 |
Why?
|
Retrospective Studies | 56 | 2024 | 81565 | 0.270 |
Why?
|
Inguinal Canal | 2 | 2005 | 71 | 0.270 |
Why?
|
Aged | 72 | 2024 | 171219 | 0.270 |
Why?
|
Decision Support Techniques | 4 | 2017 | 2006 | 0.270 |
Why?
|
Arteries | 2 | 2008 | 1121 | 0.260 |
Why?
|
Aged, 80 and over | 43 | 2024 | 59515 | 0.250 |
Why?
|
Carotid Arteries | 4 | 2002 | 932 | 0.250 |
Why?
|
Internship and Residency | 2 | 2018 | 5946 | 0.250 |
Why?
|
Polytetrafluoroethylene | 4 | 2002 | 242 | 0.250 |
Why?
|
Patient Selection | 11 | 2019 | 4249 | 0.240 |
Why?
|
Carotid Artery Diseases | 4 | 2013 | 872 | 0.240 |
Why?
|
Logistic Models | 22 | 2018 | 13273 | 0.230 |
Why?
|
Aortic Aneurysm, Thoracic | 4 | 2013 | 708 | 0.230 |
Why?
|
Wound Infection | 2 | 2017 | 244 | 0.230 |
Why?
|
Multivariate Analysis | 19 | 2018 | 12061 | 0.230 |
Why?
|
Blood Loss, Surgical | 1 | 2008 | 642 | 0.230 |
Why?
|
Heart Function Tests | 1 | 2005 | 317 | 0.220 |
Why?
|
Kidney Transplantation | 2 | 2013 | 4277 | 0.220 |
Why?
|
Chronic Disease | 12 | 2024 | 9354 | 0.220 |
Why?
|
Proportional Hazards Models | 14 | 2024 | 12529 | 0.220 |
Why?
|
Ultrasonography, Interventional | 4 | 2019 | 1520 | 0.210 |
Why?
|
Fellowships and Scholarships | 1 | 2012 | 1134 | 0.210 |
Why?
|
Thoracic Outlet Syndrome | 1 | 2024 | 97 | 0.200 |
Why?
|
Ribs | 1 | 2024 | 256 | 0.200 |
Why?
|
Prosthesis-Related Infections | 3 | 2016 | 497 | 0.200 |
Why?
|
Carotid Artery, Internal | 2 | 2024 | 440 | 0.200 |
Why?
|
Odds Ratio | 15 | 2018 | 9657 | 0.200 |
Why?
|
Male | 79 | 2024 | 363935 | 0.190 |
Why?
|
Tibial Arteries | 1 | 2002 | 60 | 0.190 |
Why?
|
Middle Aged | 57 | 2024 | 223083 | 0.190 |
Why?
|
Female | 79 | 2024 | 396233 | 0.180 |
Why?
|
Postoperative Complications | 19 | 2024 | 15808 | 0.180 |
Why?
|
Humans | 100 | 2024 | 766117 | 0.180 |
Why?
|
Constriction, Pathologic | 3 | 2015 | 1102 | 0.170 |
Why?
|
Vascular Diseases | 1 | 2008 | 1161 | 0.170 |
Why?
|
Reoperation | 13 | 2018 | 4309 | 0.170 |
Why?
|
Databases, Factual | 9 | 2021 | 8062 | 0.170 |
Why?
|
Quality Improvement | 4 | 2016 | 3849 | 0.160 |
Why?
|
Decompression, Surgical | 1 | 2024 | 602 | 0.160 |
Why?
|
Length of Stay | 14 | 2024 | 6490 | 0.160 |
Why?
|
Lumbar Vertebrae | 1 | 2008 | 1878 | 0.160 |
Why?
|
Groin | 1 | 2019 | 106 | 0.150 |
Why?
|
Spinal Fusion | 1 | 2008 | 1307 | 0.150 |
Why?
|
Tunica Intima | 3 | 1999 | 455 | 0.150 |
Why?
|
Aorta, Abdominal | 2 | 2019 | 626 | 0.150 |
Why?
|
Foot | 3 | 2010 | 576 | 0.150 |
Why?
|
Critical Illness | 6 | 2017 | 2749 | 0.150 |
Why?
|
Travel | 1 | 2024 | 806 | 0.150 |
Why?
|
Surgical Wound Infection | 5 | 2016 | 1544 | 0.140 |
Why?
|
Data Collection | 2 | 2016 | 3318 | 0.140 |
Why?
|
Angiography | 2 | 2020 | 1589 | 0.140 |
Why?
|
Learning Curve | 1 | 2018 | 232 | 0.140 |
Why?
|
Aneurysm, Ruptured | 3 | 2012 | 455 | 0.130 |
Why?
|
Aorta | 3 | 2022 | 2040 | 0.130 |
Why?
|
Recurrence | 8 | 2024 | 8494 | 0.130 |
Why?
|
Endothelial Growth Factors | 2 | 1999 | 671 | 0.130 |
Why?
|
Databases as Topic | 7 | 2011 | 472 | 0.130 |
Why?
|
Anastomosis, Surgical | 3 | 1998 | 992 | 0.120 |
Why?
|
Retreatment | 2 | 2016 | 598 | 0.120 |
Why?
|
Boston | 11 | 2017 | 9335 | 0.120 |
Why?
|
Catheterization, Peripheral | 1 | 2019 | 345 | 0.120 |
Why?
|
Lymphokines | 2 | 1999 | 905 | 0.120 |
Why?
|
Endoleak | 1 | 2016 | 111 | 0.120 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2001 | 1239 | 0.120 |
Why?
|
Plasminogen Activator Inhibitor 1 | 1 | 1996 | 279 | 0.120 |
Why?
|
Myocardial Infarction | 6 | 2018 | 11509 | 0.120 |
Why?
|
Celiac Artery | 1 | 2015 | 65 | 0.120 |
Why?
|
Silver Compounds | 1 | 2014 | 24 | 0.120 |
Why?
|
Nerve Block | 1 | 2021 | 717 | 0.110 |
Why?
|
Cyclins | 1 | 1996 | 598 | 0.110 |
Why?
|
Anesthesia, General | 1 | 2021 | 1187 | 0.110 |
Why?
|
Meglumine | 1 | 2014 | 143 | 0.110 |
Why?
|
Treatment Failure | 4 | 2019 | 2653 | 0.110 |
Why?
|
Voluntary Health Agencies | 1 | 2013 | 38 | 0.110 |
Why?
|
Muscle, Smooth, Vascular | 2 | 1999 | 1494 | 0.110 |
Why?
|
Benchmarking | 1 | 2020 | 1055 | 0.110 |
Why?
|
Renal Dialysis | 3 | 2015 | 1791 | 0.100 |
Why?
|
Stockings, Compression | 1 | 2012 | 36 | 0.100 |
Why?
|
Alginates | 1 | 2014 | 248 | 0.100 |
Why?
|
Perioperative Care | 1 | 2001 | 1043 | 0.100 |
Why?
|
Aortic Diseases | 1 | 2019 | 741 | 0.100 |
Why?
|
Bandages | 1 | 2014 | 270 | 0.100 |
Why?
|
Polyesters | 1 | 2014 | 373 | 0.100 |
Why?
|
Death, Sudden, Cardiac | 1 | 2001 | 1568 | 0.100 |
Why?
|
Aorta, Thoracic | 1 | 2019 | 1109 | 0.100 |
Why?
|
Infectious Mononucleosis | 1 | 2012 | 133 | 0.100 |
Why?
|
Autoantigens | 1 | 1996 | 886 | 0.100 |
Why?
|
Cerebrovascular Disorders | 1 | 1999 | 1478 | 0.100 |
Why?
|
Renal Artery Obstruction | 1 | 2013 | 216 | 0.100 |
Why?
|
Anti-Infective Agents, Local | 1 | 2014 | 246 | 0.100 |
Why?
|
Polyethylenes | 1 | 2014 | 289 | 0.100 |
Why?
|
Registries | 9 | 2018 | 8347 | 0.100 |
Why?
|
Stroke | 8 | 2018 | 9748 | 0.090 |
Why?
|
Sclerotherapy | 1 | 2012 | 184 | 0.090 |
Why?
|
Health Status Disparities | 2 | 2013 | 1878 | 0.090 |
Why?
|
Occupational Health | 1 | 2017 | 812 | 0.090 |
Why?
|
Genes | 1 | 1995 | 1824 | 0.090 |
Why?
|
Anti-Bacterial Agents | 1 | 2009 | 7474 | 0.090 |
Why?
|
Lung Diseases | 1 | 2021 | 1941 | 0.090 |
Why?
|
Staphylococcal Infections | 2 | 2013 | 1393 | 0.090 |
Why?
|
Organometallic Compounds | 1 | 2014 | 645 | 0.090 |
Why?
|
Pain, Postoperative | 1 | 2021 | 1768 | 0.090 |
Why?
|
Research Design | 2 | 2016 | 6206 | 0.090 |
Why?
|
Radiography, Interventional | 1 | 2017 | 1128 | 0.090 |
Why?
|
Myocardial Ischemia | 1 | 2001 | 2132 | 0.090 |
Why?
|
Predictive Value of Tests | 5 | 2020 | 15403 | 0.090 |
Why?
|
Acute Kidney Injury | 1 | 2022 | 1943 | 0.090 |
Why?
|
Renal Insufficiency, Chronic | 2 | 2022 | 2306 | 0.080 |
Why?
|
Viscera | 1 | 2010 | 138 | 0.080 |
Why?
|
Resistin | 1 | 2010 | 174 | 0.080 |
Why?
|
Surgical Procedures, Operative | 1 | 2001 | 1931 | 0.080 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 1996 | 1513 | 0.080 |
Why?
|
Radiation Dosage | 1 | 2017 | 1945 | 0.080 |
Why?
|
Survival Rate | 8 | 2013 | 12827 | 0.080 |
Why?
|
Hypoglycemic Agents | 2 | 2018 | 3107 | 0.080 |
Why?
|
Mesenteric Vascular Occlusion | 1 | 2009 | 93 | 0.080 |
Why?
|
Prospective Studies | 8 | 2024 | 54812 | 0.080 |
Why?
|
Dogs | 4 | 1998 | 3824 | 0.080 |
Why?
|
Renal Artery | 1 | 2010 | 355 | 0.070 |
Why?
|
Hemostasis, Surgical | 1 | 2008 | 128 | 0.070 |
Why?
|
International Classification of Diseases | 1 | 2013 | 934 | 0.070 |
Why?
|
Healthcare Disparities | 2 | 2013 | 3407 | 0.070 |
Why?
|
United States | 19 | 2018 | 72920 | 0.070 |
Why?
|
Occupational Exposure | 1 | 2017 | 1806 | 0.070 |
Why?
|
Insulin | 2 | 2018 | 6604 | 0.070 |
Why?
|
RNA, Messenger | 4 | 1998 | 12775 | 0.070 |
Why?
|
Magnetic Resonance Imaging, Cine | 1 | 2014 | 1093 | 0.070 |
Why?
|
Blotting, Northern | 3 | 1998 | 1546 | 0.070 |
Why?
|
Hyperplasia | 4 | 1999 | 1142 | 0.070 |
Why?
|
Severity of Illness Index | 7 | 2020 | 15882 | 0.070 |
Why?
|
Gene Expression | 2 | 1998 | 7582 | 0.060 |
Why?
|
Body Mass Index | 4 | 2017 | 13046 | 0.060 |
Why?
|
Patient Admission | 1 | 2013 | 1365 | 0.060 |
Why?
|
Glucose Tolerance Test | 1 | 2009 | 1180 | 0.060 |
Why?
|
Thinness | 1 | 2009 | 482 | 0.060 |
Why?
|
Adult | 17 | 2024 | 223139 | 0.060 |
Why?
|
E2F Transcription Factors | 1 | 2006 | 269 | 0.060 |
Why?
|
Punctures | 2 | 2019 | 372 | 0.060 |
Why?
|
Neurology | 1 | 2013 | 784 | 0.060 |
Why?
|
Curriculum | 1 | 2018 | 3784 | 0.060 |
Why?
|
Quality of Life | 2 | 2016 | 13468 | 0.060 |
Why?
|
Subclavian Vein | 1 | 2024 | 57 | 0.060 |
Why?
|
Glomerular Filtration Rate | 1 | 2013 | 2232 | 0.060 |
Why?
|
Clinical Competence | 2 | 2018 | 4859 | 0.060 |
Why?
|
Kidney Diseases | 1 | 2015 | 2100 | 0.060 |
Why?
|
Adiponectin | 1 | 2010 | 1120 | 0.060 |
Why?
|
Blood Glucose | 1 | 2018 | 6421 | 0.060 |
Why?
|
Patient Readmission | 2 | 2018 | 3283 | 0.060 |
Why?
|
Proteinuria | 1 | 2006 | 606 | 0.050 |
Why?
|
Comorbidity | 6 | 2018 | 10579 | 0.050 |
Why?
|
Ciprofloxacin | 1 | 2005 | 314 | 0.050 |
Why?
|
Image Enhancement | 1 | 2014 | 2857 | 0.050 |
Why?
|
Disease-Free Survival | 4 | 2017 | 6840 | 0.050 |
Why?
|
Suture Techniques | 1 | 2008 | 774 | 0.050 |
Why?
|
Hospital Mortality | 6 | 2013 | 5340 | 0.050 |
Why?
|
Laparoscopy | 1 | 2015 | 2040 | 0.050 |
Why?
|
Peer Review, Research | 2 | 2016 | 342 | 0.050 |
Why?
|
Hospitals | 1 | 2016 | 3887 | 0.050 |
Why?
|
Carotid Artery, Common | 1 | 2023 | 172 | 0.050 |
Why?
|
Mesenteric Artery, Superior | 1 | 2002 | 96 | 0.050 |
Why?
|
Hematoma | 2 | 2014 | 765 | 0.050 |
Why?
|
Upper Extremity | 1 | 2007 | 684 | 0.050 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2009 | 1721 | 0.050 |
Why?
|
Follow-Up Studies | 10 | 2013 | 39243 | 0.050 |
Why?
|
Delivery of Health Care | 1 | 2020 | 5367 | 0.050 |
Why?
|
Nuclear Proteins | 1 | 1996 | 5791 | 0.050 |
Why?
|
Asymptomatic Diseases | 2 | 2016 | 586 | 0.050 |
Why?
|
Blood Transfusion | 1 | 2008 | 1307 | 0.050 |
Why?
|
Heart Failure | 2 | 2005 | 11837 | 0.050 |
Why?
|
New England | 2 | 2016 | 1059 | 0.050 |
Why?
|
Practice Guidelines as Topic | 3 | 2013 | 7424 | 0.050 |
Why?
|
Incidence | 6 | 2016 | 21513 | 0.050 |
Why?
|
Myocardium | 1 | 2014 | 4766 | 0.050 |
Why?
|
Clavicle | 1 | 2023 | 224 | 0.050 |
Why?
|
Aneurysm | 1 | 2004 | 343 | 0.050 |
Why?
|
Myocardial Revascularization | 1 | 2005 | 795 | 0.050 |
Why?
|
Endarterectomy | 2 | 2013 | 196 | 0.040 |
Why?
|
Emergency Medical Services | 2 | 2009 | 1937 | 0.040 |
Why?
|
Age Factors | 5 | 2016 | 18386 | 0.040 |
Why?
|
Vascular Endothelial Growth Factors | 2 | 1999 | 748 | 0.040 |
Why?
|
Overweight | 1 | 2010 | 2444 | 0.040 |
Why?
|
Osteotomy | 1 | 2024 | 835 | 0.040 |
Why?
|
Decision Making | 1 | 2012 | 3955 | 0.040 |
Why?
|
Inpatients | 1 | 2010 | 2566 | 0.040 |
Why?
|
Extremities | 1 | 2004 | 868 | 0.040 |
Why?
|
Interferon-gamma | 2 | 1999 | 3159 | 0.040 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2009 | 10380 | 0.040 |
Why?
|
Sex Factors | 4 | 2013 | 10614 | 0.040 |
Why?
|
Patient Care Team | 1 | 2009 | 2517 | 0.040 |
Why?
|
Health Care Costs | 1 | 2011 | 3243 | 0.040 |
Why?
|
Morbidity | 1 | 2003 | 1753 | 0.040 |
Why?
|
Anti-Infective Agents | 1 | 2005 | 987 | 0.040 |
Why?
|
Survival Analysis | 5 | 2013 | 10087 | 0.040 |
Why?
|
Life Tables | 1 | 2017 | 366 | 0.030 |
Why?
|
Radiation Monitoring | 1 | 2017 | 106 | 0.030 |
Why?
|
Heart Valve Prosthesis | 1 | 2005 | 1464 | 0.030 |
Why?
|
Immunohistochemistry | 4 | 1999 | 11035 | 0.030 |
Why?
|
Cloning, Molecular | 3 | 1999 | 4163 | 0.030 |
Why?
|
Consensus | 2 | 2016 | 3202 | 0.030 |
Why?
|
Diabetes Mellitus, Type 1 | 2 | 2017 | 3445 | 0.030 |
Why?
|
Obesity | 2 | 2009 | 13085 | 0.030 |
Why?
|
Antigens, Nuclear | 1 | 1996 | 182 | 0.030 |
Why?
|
Patient Discharge | 3 | 2013 | 3465 | 0.030 |
Why?
|
Preoperative Care | 1 | 2005 | 2249 | 0.030 |
Why?
|
Captopril | 1 | 1996 | 261 | 0.030 |
Why?
|
Thrombolytic Therapy | 1 | 2024 | 2051 | 0.030 |
Why?
|
Periodicals as Topic | 2 | 2016 | 1463 | 0.030 |
Why?
|
Arrhythmias, Cardiac | 1 | 2005 | 2255 | 0.030 |
Why?
|
Hemorrhage | 2 | 2019 | 3466 | 0.030 |
Why?
|
C-Reactive Protein | 1 | 2006 | 3853 | 0.030 |
Why?
|
Hexuronic Acids | 1 | 2014 | 145 | 0.030 |
Why?
|
Glucuronic Acid | 1 | 2014 | 149 | 0.030 |
Why?
|
Ki-67 Antigen | 1 | 1996 | 628 | 0.030 |
Why?
|
alpha 1-Antitrypsin | 1 | 1995 | 168 | 0.030 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 1995 | 1056 | 0.030 |
Why?
|
Stroke Volume | 1 | 2007 | 5595 | 0.030 |
Why?
|
Muscle Proteins | 1 | 1999 | 1160 | 0.030 |
Why?
|
Fluoroscopy | 1 | 2017 | 945 | 0.030 |
Why?
|
Texas | 1 | 2014 | 409 | 0.030 |
Why?
|
Intention to Treat Analysis | 1 | 2014 | 418 | 0.030 |
Why?
|
Creatine Kinase | 1 | 1995 | 682 | 0.030 |
Why?
|
Thrombosis | 2 | 2019 | 2955 | 0.030 |
Why?
|
Cohort Studies | 5 | 2012 | 41684 | 0.030 |
Why?
|
Administration, Topical | 1 | 2014 | 702 | 0.030 |
Why?
|
Staphylococcus epidermidis | 1 | 2013 | 121 | 0.030 |
Why?
|
Retinoblastoma | 1 | 1995 | 316 | 0.020 |
Why?
|
Graft Survival | 3 | 2010 | 3904 | 0.020 |
Why?
|
In Situ Hybridization | 1 | 1996 | 1885 | 0.020 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2024 | 2768 | 0.020 |
Why?
|
Prevalence | 1 | 2009 | 15827 | 0.020 |
Why?
|
Aneurysm, False | 1 | 2014 | 264 | 0.020 |
Why?
|
Workload | 1 | 2017 | 849 | 0.020 |
Why?
|
DNA, Complementary | 1 | 1995 | 1984 | 0.020 |
Why?
|
Vascular System Injuries | 1 | 2014 | 245 | 0.020 |
Why?
|
Hospitals, University | 1 | 2013 | 573 | 0.020 |
Why?
|
Recovery of Function | 1 | 2021 | 2971 | 0.020 |
Why?
|
Pain Measurement | 1 | 2021 | 3576 | 0.020 |
Why?
|
Heart Diseases | 2 | 2004 | 2818 | 0.020 |
Why?
|
Clinical Trials as Topic | 2 | 2016 | 8038 | 0.020 |
Why?
|
Life Expectancy | 1 | 2017 | 1248 | 0.020 |
Why?
|
Aortography | 1 | 2012 | 423 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor A | 2 | 1999 | 3501 | 0.020 |
Why?
|
Equipment Design | 1 | 2017 | 3489 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2020 | 20137 | 0.020 |
Why?
|
Ankle Brachial Index | 1 | 2010 | 164 | 0.020 |
Why?
|
Gadolinium | 1 | 2014 | 966 | 0.020 |
Why?
|
Interdisciplinary Communication | 1 | 2015 | 931 | 0.020 |
Why?
|
Adolescent | 4 | 2024 | 88819 | 0.020 |
Why?
|
Prosthesis Design | 1 | 2016 | 2111 | 0.020 |
Why?
|
Young Adult | 4 | 2024 | 59868 | 0.020 |
Why?
|
Electrocardiography | 2 | 2014 | 6409 | 0.020 |
Why?
|
Prognosis | 2 | 2006 | 29912 | 0.020 |
Why?
|
Embolectomy | 1 | 2009 | 130 | 0.020 |
Why?
|
American Heart Association | 1 | 2013 | 1045 | 0.020 |
Why?
|
Base Sequence | 2 | 1999 | 12405 | 0.020 |
Why?
|
Heart Arrest | 1 | 2018 | 1516 | 0.020 |
Why?
|
Adipokines | 1 | 2010 | 308 | 0.020 |
Why?
|
Disease Progression | 2 | 2013 | 13616 | 0.020 |
Why?
|
Device Removal | 1 | 2013 | 643 | 0.020 |
Why?
|
Molecular Weight | 1 | 2010 | 2161 | 0.020 |
Why?
|
Cooperative Behavior | 1 | 2015 | 1512 | 0.020 |
Why?
|
Radiography | 2 | 2012 | 6943 | 0.020 |
Why?
|
RNA | 1 | 1997 | 2716 | 0.020 |
Why?
|
Risk | 1 | 1999 | 9599 | 0.020 |
Why?
|
Kidney | 1 | 2022 | 7072 | 0.020 |
Why?
|
History, 21st Century | 1 | 2013 | 1574 | 0.020 |
Why?
|
Health Services Accessibility | 1 | 2024 | 5510 | 0.020 |
Why?
|
Emergencies | 1 | 2013 | 1224 | 0.020 |
Why?
|
Animals | 6 | 2005 | 168800 | 0.020 |
Why?
|
ROC Curve | 1 | 2014 | 3614 | 0.020 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 1 | 2013 | 705 | 0.020 |
Why?
|
Embolization, Therapeutic | 1 | 2016 | 1405 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 1995 | 6059 | 0.020 |
Why?
|
Rats | 2 | 2005 | 23717 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2012 | 21074 | 0.020 |
Why?
|
Transplantation, Autologous | 1 | 2010 | 2125 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 1996 | 8113 | 0.010 |
Why?
|
Analgesics, Opioid | 1 | 2021 | 3836 | 0.010 |
Why?
|
Probability | 1 | 2010 | 2475 | 0.010 |
Why?
|
Hospital Costs | 1 | 2010 | 955 | 0.010 |
Why?
|
Confidence Intervals | 1 | 2010 | 2915 | 0.010 |
Why?
|
Algorithms | 1 | 2005 | 14066 | 0.010 |
Why?
|
Epidemiologic Methods | 1 | 2009 | 1325 | 0.010 |
Why?
|
Ultrasonography, Doppler | 1 | 2006 | 463 | 0.010 |
Why?
|
Physician-Patient Relations | 1 | 2017 | 3270 | 0.010 |
Why?
|
Physical Examination | 1 | 2010 | 1263 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2009 | 2844 | 0.010 |
Why?
|
Magnetic Resonance Angiography | 1 | 2010 | 1429 | 0.010 |
Why?
|
Communication | 1 | 2017 | 3909 | 0.010 |
Why?
|
Ambulatory Care | 1 | 2013 | 2778 | 0.010 |
Why?
|
Los Angeles | 1 | 2002 | 244 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2014 | 10737 | 0.010 |
Why?
|
Materials Testing | 1 | 2005 | 868 | 0.010 |
Why?
|
Postoperative Period | 1 | 2006 | 1820 | 0.010 |
Why?
|
Rats, Wistar | 1 | 2005 | 1886 | 0.010 |
Why?
|
Endocarditis, Bacterial | 1 | 2005 | 434 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2013 | 8525 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 1995 | 7600 | 0.010 |
Why?
|
Contrast Media | 1 | 2014 | 5330 | 0.010 |
Why?
|
Intraoperative Complications | 1 | 2007 | 1169 | 0.010 |
Why?
|
Massachusetts | 1 | 2013 | 8882 | 0.010 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2003 | 12235 | 0.010 |
Why?
|
Population Surveillance | 1 | 2009 | 2596 | 0.010 |
Why?
|
Models, Animal | 1 | 2005 | 2120 | 0.010 |
Why?
|
Transforming Growth Factor alpha | 1 | 1999 | 134 | 0.010 |
Why?
|
Reference Values | 1 | 2006 | 4909 | 0.010 |
Why?
|
Ischemic Attack, Transient | 1 | 2003 | 871 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-sis | 1 | 1999 | 254 | 0.010 |
Why?
|
Mortality | 1 | 2009 | 2911 | 0.010 |
Why?
|
DNA Probes | 1 | 1998 | 541 | 0.010 |
Why?
|
Mitral Valve | 1 | 2005 | 1475 | 0.010 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 1999 | 590 | 0.010 |
Why?
|
Ultrasonography | 1 | 2010 | 5988 | 0.010 |
Why?
|
Platelet-Derived Growth Factor | 1 | 1999 | 614 | 0.010 |
Why?
|
Molecular Sequence Data | 2 | 1999 | 17597 | 0.010 |
Why?
|
Forecasting | 1 | 2005 | 2936 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2010 | 14645 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2010 | 14747 | 0.010 |
Why?
|
Graft Rejection | 1 | 2006 | 4504 | 0.010 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 1999 | 1318 | 0.010 |
Why?
|
Pneumonia | 1 | 2004 | 2159 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2006 | 12426 | 0.010 |
Why?
|
Blotting, Western | 1 | 1999 | 5020 | 0.010 |
Why?
|
Up-Regulation | 1 | 1999 | 4133 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2012 | 20700 | 0.000 |
Why?
|
Cells, Cultured | 1 | 1999 | 18967 | 0.000 |
Why?
|